Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)

NCT03003416 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03003416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03003416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
October 19, 2017
Completion date
December 19, 2018
Enrollment
115 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema